Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
AssigneeBoehringer Ingelheim Pharma GmbH & Co. KG
InventorsBirgit Jung, Michel Pairet, Michael P. Pieper
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.
Claims12
A pharmaceutical composition comprising one or more anticholinergics combined with one or more EGFR kinase inhibitors, in the form of the enantiomers, mixtures of the enantiomers or in the form of the racemates thereof, or in the form of the solvates or hydrates.
A method for treating inflammatory or obstructive diseases of the respiratory tract in a warm-blooded animal which comprises administering to the animal a therapeutically effective amount of at least one anticholinergic together with a therapeutically effective amount of at least one EGFR kinase inhibitor.
Dependencies are inferred from the claim text.